Short interest in Virax Biolabs Group Ltd (NASDAQ:VRAX) decreased during the last reporting period, falling from 284.03K to 144.63K. This put 3.57% of the company's publicly available shares short.

Short interest for Virax Biolabs Group gives investors a sense of the degree to which investors are betting on the decline of Virax Biolabs Group's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 182.31K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.